| ID | Sequence | Length | GC content |
|---|---|---|---|
| AUUUCCGAUCCGGGCCAAGGCUGGGUGGCUGCGGCAGUGCCGGAGGCCC… | 1549 nt | 0.5094 | |
| GCCAUUAACAAAGAUGGUGCUUAUGGGGCAGGUUCCCUAACAGUCAGGA… | 1193 nt | 0.5381 | |
| GCCAUUAACAAAGAUGGUGCUUAUGGGGCAGGUUCCCUAACAGUCAGGA… | 635 nt | 0.5150 | |
| GGAGAAAUGGAGGCCAGAGACAAACAAGUACUCCGCUCACUUCGCCUGG… | 756 nt | 0.5053 | |
| GCCAUUAACAAAGAUGGUGCUUAUGGGGCAGGUUCCCUAACAGUCAGGA… | 1189 nt | 0.4794 |
This gene encodes a protein containing a death domain (DD) motif. This protein recruits caspase 2/ICH1 to the cell death signal transduction complex, which includes tumor necrosis factor receptor 1 (TNFR1A) and RIPK1/RIP kinase, and acts in promoting apoptosis. A mutation in this gene was associated with cognitive disability. A related pseudogene is found on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
A study in human cadavers demonstrated that the CRADD was down-regulated (-17,328.3091 fold) in decaying liver tissues compared to a control, as part of the apoptotic thanatotranscriptome where mRNA remains stable for analysis up to 48 hours postmortem [Javan et al. DOI:10.1007/S12024-015-9704-6].